MobiHealth News October 10, 2025
The two companies will develop affordable peptide therapies aimed at extending women’s lifespan.
Women’s telehealth company Wisp announced a strategic partnership with Vesalius Longevity Labs, a company that provides regenerative medicine, to develop an exclusive range of peptide therapies aimed at advancing women’s quality of life and promoting longevity.
Wisp and Vesalius Longevity Labs will assess emerging longevity AI platforms, including AI tools that strengthen personalized care, clinical decision support and patient engagement, for possible integration into its services.
The two companies will also explore opportunities for strategic investment in AI tools that boost personalized care, clinical decision support and patient engagement.
Wisp focuses on birth control, fertility issues, menopause and STI testing. The company’s licensed medical providers review patient...
Today's Sponsors
Today's Sponsor